DrugPatentWatch Database Preview
Patent: 8,258,098
» See Plans and Pricing
Summary for Patent: 8,258,098
Title: | Antitumoral treatments |
Abstract: | The present invention relates to combinations of aplidine or aplidine analogues with other titumoral agents, and the use of these combinations in the treatment of cancer, in particular in the treatment of lung cancer, breast cancer, colon cancer, prostate cancer, renal cancer, melanoma, multiple myeloma, leukemia and lymphoma. |
Inventor(s): | Faircloth; Glynn Thomas (Cambridge, MA), Aviles Marin; Pablo Manuel (Madrid, ES), LePage; Doreen (Cambridge, MA), Izquierdo; Jesus San Miguel (Salamanca, ES), Pandiella; Atanasio (Salamanca, ES) |
Assignee: | Pharma Mar, S.A. (Madrid, ES) |
Application Number: | 12/278,559 |
Patent Claims: | see list of patent claims |
Details for Patent 8,258,098
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Genentech Inc | RITUXAN HYCELA | rituximab; hyaluronidase (human recombinant) | SOLUTION;SUBCUTANEOUS | 761064 | 002 | 2017-06-22 | Start Trial | Pharma Mar, S.A. (Madrid, ES) | 2039-03-29 | RX | Orphan | search |
Genentech Inc | RITUXAN HYCELA | rituximab; hyaluronidase (human recombinant) | SOLUTION;SUBCUTANEOUS | 761064 | 001 | 2017-06-22 | Start Trial | Pharma Mar, S.A. (Madrid, ES) | 2039-03-29 | RX | Orphan | search |
Genentech | RITUXAN | rituximab | SOLUTION;INTRAVENOUS | 103705 | 002 | 1997-11-26 | Start Trial | Pharma Mar, S.A. (Madrid, ES) | 2039-03-29 | RX | search | |
Genentech | RITUXAN | rituximab | SOLUTION;INTRAVENOUS | 103705 | 001 | 1997-11-26 | Start Trial | Pharma Mar, S.A. (Madrid, ES) | 2039-03-29 | RX | search | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 8,258,098
Country | Patent Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 2007101235 | Start Trial |
United States of America | 2009246168 | Start Trial |
Slovenia | 2029155 | Start Trial |
Russian Federation | 2008138560 | Start Trial |
Russian Federation | 2481853 | Start Trial |
Serbia | 54928 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |